Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
#PreAANChat: NeurologyLive to Host Pre-AAN 2024 Social Chat
Episode 108: Advancing the Genetic Pool of Parkinson Disease
FDA-Approved Injection DaxibotulinumtoxinA Shows Efficacy for Cervical Dystonia Treatment in Phase 3 ASPEN-1 Trial
Paradigm Shift in Parkinson’s Disease Diagnosis
UB-312 Reduces α-Synuclein in Parkinson Disease in Phase 1 Trial
NeurologyLive® Brain Games: March 17, 2024